#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Mitochondrial myopathy Angiosarcoma Oesophageal atresia Small for dates baby Univentricular heart Advanced systemic mastocytosis Renal cell carcinoma Malignant fibrous histiocytoma Primitive neuroectodermal tumour Anti-myelin-associated glycoprotein antibodies positive Congenital nephrogenic diabetes insipidus Complex regional pain syndrome Small intestine leiomyosarcoma Retinal artery occlusion More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Trials in Disease Primary biliary cholangitis Leiomyosarcoma recurrent – Life with Disease Glomerulonephritis membranous – Basic Information Fragile X syndrome – Life with Disease Myelodysplastic syndrome – Diagnostics Mitochondrial myopathy – Treatment Basal cell naevus syndrome – Basic Information Pelizaeus-Merzbacher disease – Life with Disease Hereditary angioedema – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cilgavimab Pimavanserin Tartrate Placebo GUAIACOL Riboflavin Sodium Phosphate Mycophenolate Sodium Int-787 Azd0901 Gen1055 Paracetamol Dc Pregabalin Tecovirimat Itepekimab Dimethyl Fumarate Povorcitinib Forimtamig Trifluridine ILOPROST Poractant Alfa Betula Verrucosa Pollen More therapies…

    Learn about Your Condition

    Acute leukaemia Bladder cancer recurrent Oedema Naevus flammeus Hypotransferrinaemia Eosinophilic oesophagitis Perinatal depression Colorectal cancer Reperfusion injury Urinary incontinence Monkeypox Glucose tolerance impaired Adenovirus infection Hepatoblastoma Plasma cell myeloma refractory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Ianalumab
    Austria Belgium Czechia France Germany Lithuania +3

  • Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Radium Ra 223 Dichloride
    • Enzalutamide
    Belgium Denmark France Ireland Italy Norway +2

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Italy +2

  • Study on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Enfortumab Vedotin
    • Tremelimumab
    • Durvalumab
    Austria France Germany Greece Italy The Netherlands +3

  • Study of Atezolizumab and Chemotherapy for Patients with Non-Resectable Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    Spain

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Goserelin
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4

  • Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Italy Poland Spain

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain

  • Study on the Safety and Tolerability of Lasmiditan for Treating Migraine in Children Aged 6 to 17

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Lasmiditan
    Belgium France Germany Italy The Netherlands Romania +1

  • Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Systemic Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Drugs:
    • Deucravacitinib
    Hungary Poland Romania Spain
Previous Page
1 … 22 23 24 25 26 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!